Trial · NCT00965991
Metformin Compared to Glyburide in Gestational Diabetes
NCT00965991, Not applicable, Completed, University of New Mexico; results first posted 2023-12-21
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Metformin Compared to Glyburide in Gestational Diabetes. Trials, record NCT00965991. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00965991
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Metformin Compared to Glyburide in Gestational Diabetes
- NCT number
- NCT00965991
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 149 participants, actual
- Lead sponsor
- University of New Mexico
- Conditions
- Gestational Diabetes
- Interventions
- metformin, Glyburide
- First posted
- 2009-08-26
- Last updated
- 2024-11-19
- Results first posted
- 2023-12-21
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants Assessed for Glucose Control | fasting and 2 hour postprandial blood glucose | The importance of exercise in the management of blood glucose was emphasized, and 30 minutes of walking per day was recommended. Patients received instruction from a nurse educator or a certified diabetes educator regarding diet and the use of the glucometer. Number of participants with a glucose level \<100 mg/dL. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants Assessed for Glucose Control | fasting and 2 hour postprandial blood glucose | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Assessed for Glucose Control | Metformin | 50 | Participants | ||
| Number of Participants Assessed for Glucose Control | Glyburide | 50 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | ARM 1: Metformin | 75 | |
| Overall Study | STARTED | ARM 2: Glyburide | 74 | |
| Overall Study | COMPLETED | ARM 1: Metformin | 75 | |
| Overall Study | COMPLETED | ARM 2: Glyburide | 74 | |
| Overall Study | NOT COMPLETED | ARM 1: Metformin | 0 | |
| Overall Study | NOT COMPLETED | ARM 2: Glyburide | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | ARM 1: Metformin | 0 | 75 |
| Total, all-cause mortality | ARM 2: Glyburide | 0 | 74 |
| Total, other adverse events | ARM 1: Metformin | 0 | 75 |
| Total, other adverse events | ARM 2: Glyburide | 0 | 74 |
| Total, serious adverse events | ARM 1: Metformin | 0 | 75 |
| Total, serious adverse events | ARM 2: Glyburide | 0 | 74 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 20027034 | RESULT |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Metformin vs Glyburide: Number of Participants Assessed for Glucose Control | Trial comparisons |
| ARM 1: Metformin vs ARM 2: Glyburide: deaths from any cause | Trial comparisons |
| ARM 1: Metformin vs ARM 2: Glyburide: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00965991
GET https://conductscience.org/api/trials/v1/NCT00965991/registered